DE60003445D1 - Pharmazeutische zusammensetzungen ein fluorchinolonantibiotikum und xanthangummi enthaltend - Google Patents

Pharmazeutische zusammensetzungen ein fluorchinolonantibiotikum und xanthangummi enthaltend

Info

Publication number
DE60003445D1
DE60003445D1 DE60003445T DE60003445T DE60003445D1 DE 60003445 D1 DE60003445 D1 DE 60003445D1 DE 60003445 T DE60003445 T DE 60003445T DE 60003445 T DE60003445 T DE 60003445T DE 60003445 D1 DE60003445 D1 DE 60003445D1
Authority
DE
Germany
Prior art keywords
fluorochinolonantibiotic
pharmaceutical compositions
compositions containing
xanthan gum
xanthan
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60003445T
Other languages
English (en)
Other versions
DE60003445T2 (de
Inventor
P Kabra
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Alcon Inc
Original Assignee
Alcon Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Alcon Inc filed Critical Alcon Inc
Publication of DE60003445D1 publication Critical patent/DE60003445D1/de
Application granted granted Critical
Publication of DE60003445T2 publication Critical patent/DE60003445T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/14—Alkali metal chlorides; Alkaline earth metal chlorides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Ophthalmology & Optometry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
DE60003445T 1999-11-01 2000-10-10 Pharmazeutische zusammensetzungen ein fluorchinolonantibiotikum und xanthangummi enthaltend Expired - Lifetime DE60003445T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US16269399P 1999-11-01 1999-11-01
PCT/US2000/028031 WO2001032181A2 (en) 1999-11-01 2000-10-10 Pharmaceutical compositions containing a fluoroquinolone antibiotic drug and xanthan gum

Publications (2)

Publication Number Publication Date
DE60003445D1 true DE60003445D1 (de) 2003-07-24
DE60003445T2 DE60003445T2 (de) 2003-12-24

Family

ID=22586735

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60003445T Expired - Lifetime DE60003445T2 (de) 1999-11-01 2000-10-10 Pharmazeutische zusammensetzungen ein fluorchinolonantibiotikum und xanthangummi enthaltend

Country Status (19)

Country Link
US (1) US6331540B1 (de)
EP (1) EP1225898B1 (de)
JP (1) JP2003513046A (de)
KR (1) KR20020048967A (de)
CN (1) CN1384745A (de)
AR (1) AR026227A1 (de)
AT (1) ATE243038T1 (de)
AU (1) AU8008300A (de)
BR (1) BR0015256A (de)
CA (1) CA2386822A1 (de)
DE (1) DE60003445T2 (de)
DK (1) DK1225898T3 (de)
ES (1) ES2199873T3 (de)
HK (1) HK1045940A1 (de)
MX (1) MXPA02004349A (de)
PL (1) PL354928A1 (de)
PT (1) PT1225898E (de)
TR (1) TR200201174T2 (de)
WO (1) WO2001032181A2 (de)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050009922A1 (en) * 2001-01-27 2005-01-13 Carlson Paul E. Stable aqueous antimicrobial suspension
CN100488981C (zh) * 2001-08-24 2009-05-20 维多利亚大学创新和发展公司 含有蛋白酶激活序列的气单胞菌溶素原及其应用
AU2003252746A1 (en) * 2002-07-31 2004-02-16 Senju Pharmaceutical Co., Ltd. Aqueous liquid preparations and light-stabilized aqueous liquid preparations
US8877168B1 (en) 2002-07-31 2014-11-04 Senju Pharmaceuticals Co., Ltd. Aqueous liquid preparations and light-stabilized aqueous liquid preparations
US8524734B2 (en) 2005-05-18 2013-09-03 Mpex Pharmaceuticals, Inc. Aerosolized fluoroquinolones and uses thereof
WO2006125132A2 (en) * 2005-05-18 2006-11-23 Mpex Pharmaceuticals, Inc. Aerosolized fluoroquinolones and uses thereof
CN101547695B (zh) * 2006-10-12 2011-04-27 杏林制药株式会社 具有改进的加替沙星眼内渗透性的含水液体制剂
MX2010010686A (es) * 2008-03-31 2011-02-23 Kyorin Seiyaku Kk Preparacion liquida acuosa que contiene gatifloxacina, su produccion y metodo para suprimir la formacion de precipitado durante el almacenamiento a temperatura mas baja y en el momento del congelamiento y descongelamiento de la preparacion liquida ac
WO2009123099A1 (ja) 2008-03-31 2009-10-08 杏林製薬株式会社 ガチフロキサシン含有水性液剤
TWI495469B (zh) * 2008-06-09 2015-08-11 Alcon Res Ltd 含有氟喹諾酮抗生素藥物之經改良藥學組成物
US8815838B2 (en) 2008-10-07 2014-08-26 David C. Griffith Aerosol fluoroquinolone formulations for improved pharmacokinetics
PL2346509T3 (pl) 2008-10-07 2021-03-08 Horizon Orphan Llc Lewofloksacyna w postaci aerozolu dla zmniejszania stanu zapalnego płuc
ES2739979T3 (es) 2009-09-04 2020-02-05 Horizon Orphan Llc Uso de levofloxacino en aerosol para el tratamiento de la fibrosis quística
WO2011105431A1 (ja) * 2010-02-24 2011-09-01 森永乳業株式会社 昆布抽出物を有効成分とする抗菌補助剤、抗菌組成物、及び飲食品
US9050357B2 (en) * 2010-03-08 2015-06-09 Cp Kelco U.S., Inc. Compositions and methods for producing consumables for patients with dysphagia
GR1008168B (el) 2013-03-14 2014-04-08 "Φαρματεν Α.Β.Ε.Ε.", Παρεντερικο σκευασμα αντιβακτηριακου παραγοντα φθοριοκινολονης και μεθοδος για την παρασκευη αυτου
JP6602534B2 (ja) * 2013-09-27 2019-11-06 三栄源エフ・エフ・アイ株式会社 液状とろみ剤
JP6538322B2 (ja) * 2013-09-27 2019-07-03 三栄源エフ・エフ・アイ株式会社 液状とろみ剤
JP6713728B2 (ja) * 2015-05-01 2020-06-24 三栄源エフ・エフ・アイ株式会社 液状増粘剤
BR112020000196A2 (pt) 2017-07-07 2020-07-07 Epicentrx, Inc. composições para administração parenteral de agentes terapêuticos
US11484538B2 (en) 2020-08-26 2022-11-01 Somerset Therapeutics, Llc Bromfenac, prednisolone, and moxifloxacin compositions and methods
US12016855B2 (en) 2020-08-26 2024-06-25 Somerset Therapeutics, Llc Prednisolone and moxifloxacin compositions and methods
US11523987B2 (en) 2020-08-26 2022-12-13 Somerset Therapeutics, Llc Trimcinolone and moxifloxacin methods

Family Cites Families (47)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3944427A (en) 1970-04-06 1976-03-16 Itek Corporation Gelable and gelled compositions
US3700451A (en) 1970-04-06 1972-10-24 Itek Corp Gelable and gelled compositions
US3784712A (en) 1970-12-23 1974-01-08 Gen Foods Corp Gum gelling system xanthan-tara dessert gel
CA1070629A (en) 1975-11-10 1980-01-29 Allen I. Laskin Process for modifying biopolymers
US4135979A (en) 1976-08-24 1979-01-23 Merck & Co., Inc. Treatment of xanthan gum to improve clarity
US4136178A (en) 1977-01-31 1979-01-23 American Home Products Corp. Locust bean gum therapeutic compositions
US4136173A (en) 1977-01-31 1979-01-23 American Home Products Corp. Mixed xanthan gum and locust beam gum therapeutic compositions
US4136177A (en) 1977-01-31 1979-01-23 American Home Products Corp. Xanthan gum therapeutic compositions
GB8318403D0 (en) 1983-07-07 1983-08-10 Sutherland I W Gel-forming polysaccharides
FR2551087B1 (fr) 1983-08-30 1986-03-21 Rhone Poulenc Spec Chim Procede de traitement d'une solution de polysaccharide et son utilisation
DE3335593A1 (de) 1983-09-30 1985-04-11 Diamalt AG, 8000 München Gelier- und verdickungsmittel auf der basis von cassia-galactomannanen
US4717713A (en) 1983-10-31 1988-01-05 Research Corporation Controlled release liquid pharmaceutical
US4708861A (en) 1984-02-15 1987-11-24 The Liposome Company, Inc. Liposome-gel compositions
FR2588189B1 (fr) 1985-10-03 1988-12-02 Merck Sharp & Dohme Composition pharmaceutique de type a transition de phase liquide-gel
US4647470A (en) 1985-11-27 1987-03-03 Merck & Co., Inc. Low-acetyl gellan gum blends
FR2618333B1 (fr) 1987-07-20 1990-07-13 Merck Sharp & Dohme Composition pharmaceutique et/ou cosmetique a usage topique contenant de la gomme rhamsam
US5192535A (en) 1988-02-08 1993-03-09 Insite Vision Incorporated Ophthalmic suspensions
US4814160A (en) 1988-03-01 1989-03-21 Colgate-Palmolive Company Non-bleeding striped dentifrice
US5446070A (en) 1991-02-27 1995-08-29 Nover Pharmaceuticals, Inc. Compositions and methods for topical administration of pharmaceutically active agents
US5234957A (en) 1991-02-27 1993-08-10 Noven Pharmaceuticals, Inc. Compositions and methods for topical administration of pharmaceutically active agents
DE3843416A1 (de) 1988-12-23 1990-06-28 Wolff Walsrode Ag Xanthan mit verbesserter loeslichkeit und verfahren zur herstellung
CA2021414C (en) 1989-07-25 2004-09-28 Daniel H. Doherty Genetic control of acetylation and pyruvylation of xanthan gum
US5461081A (en) 1989-09-28 1995-10-24 Alcon Laboratories, Inc. Topical ophthalmic pharmaceutical vehicles
FR2653021A1 (fr) 1989-10-17 1991-04-19 Merck Sharp & Dohme Composition ophtalmique aqueuse liquide a transition de phase liquide-gel.
DE69212850T2 (de) 1991-01-15 1997-03-06 Alcon Lab Inc Verwendung von Karrageenan in topischen ophthalmologischen Zusammensetzungen
US5212162A (en) 1991-03-27 1993-05-18 Alcon Laboratories, Inc. Use of combinations gelling polysaccharides and finely divided drug carrier substrates in topical ophthalmic compositions
ES2111083T3 (es) 1991-09-17 1998-03-01 Alcon Lab Inc Composiciones que contienen antibioticos de quinolona y poli(sulfonato de estireno).
US5192802A (en) 1991-09-25 1993-03-09 Mcneil-Ppc, Inc. Bioadhesive pharmaceutical carrier
US5318780A (en) 1991-10-30 1994-06-07 Mediventures Inc. Medical uses of in situ formed gels
US5473062A (en) 1992-10-29 1995-12-05 Takeda Chemical Industries, Ltd. Process for producing purified xanthan gum
JP3228315B2 (ja) 1993-04-23 2001-11-12 信越化学工業株式会社 キサンタンガムの汚染生菌数を減少させる方法
ES2068762B1 (es) * 1993-07-21 1995-12-01 Lipotec Sa Un nuevo preparado farmaceutico para mejorar la biodisponibilidad de drogas de dificil absorcion y procedimiento para su obtencion.
JPH09510961A (ja) 1994-01-14 1997-11-04 ジュニア シャヒニアン，リー 持続性および長期間の角膜鎮痛の方法
US5422116A (en) 1994-02-18 1995-06-06 Ciba-Geigy Corporation Liquid ophthalmic sustained release delivery system
DK1125577T3 (da) 1994-04-08 2006-06-19 Qlt Usa Inc Væskeformige medikamentindföringspræparater
US5523301A (en) 1994-08-05 1996-06-04 Merck & Co., Inc. Optic nerve health
WO1996006597A1 (en) 1994-08-30 1996-03-07 Alcon Laboratories, Inc. Thermally-gelling ophthalmic drug delivery vehicles containing cellulose ethers
US5972326A (en) 1995-04-18 1999-10-26 Galin; Miles A. Controlled release of pharmaceuticals in the anterior chamber of the eye
FR2742336B1 (fr) 1995-12-19 1998-03-06 Chauvin Lab Sa Collyre destine notamment au traitement de l'oeil sec
SE9603480L (sv) 1996-09-23 1998-03-24 Johan Carlfors Beredningsform för svårlösliga läkemedel
FR2754712B1 (fr) 1996-10-17 1999-09-03 Merck Sharp Dohme Chibret Lab Compositions ophtalmiques
US5888493A (en) 1996-12-05 1999-03-30 Sawaya; Assad S. Ophthalmic aqueous gel formulation and related methods
CA2291777A1 (en) 1997-05-30 1998-12-03 Merck & Co., Inc. Ophthalmic compositions for treating ocular hypertension
AU740874B2 (en) 1997-06-26 2001-11-15 Merck & Co., Inc. Method for optimizing retinal and optic nerve health
JP2001516712A (ja) * 1997-09-12 2001-10-02 ザ、プロクター、エンド、ギャンブル、カンパニー 皮膚又は毛髪用クレンジング及びコンディショニング製品
CN1133466C (zh) * 1998-04-07 2004-01-07 阿尔康实验室公司 含有黄原胶的胶凝性眼用组合物
US6166012A (en) * 1999-07-30 2000-12-26 Allergan Sales, Inc. Antibiotic compositions and method for using same

Also Published As

Publication number Publication date
AU8008300A (en) 2001-05-14
DE60003445T2 (de) 2003-12-24
EP1225898B1 (de) 2003-06-18
MXPA02004349A (es) 2003-09-22
DK1225898T3 (da) 2003-09-15
WO2001032181A2 (en) 2001-05-10
CA2386822A1 (en) 2001-05-10
EP1225898A2 (de) 2002-07-31
CN1384745A (zh) 2002-12-11
PL354928A1 (en) 2004-03-22
KR20020048967A (ko) 2002-06-24
BR0015256A (pt) 2002-06-18
ATE243038T1 (de) 2003-07-15
JP2003513046A (ja) 2003-04-08
TR200201174T2 (tr) 2002-08-21
ES2199873T3 (es) 2004-03-01
HK1045940A1 (zh) 2002-12-20
WO2001032181A3 (en) 2002-05-02
PT1225898E (pt) 2003-10-31
AR026227A1 (es) 2003-01-29
US6331540B1 (en) 2001-12-18

Similar Documents

Publication Publication Date Title
DE60003445T2 (de) Pharmazeutische zusammensetzungen ein fluorchinolonantibiotikum und xanthangummi enthaltend
DE69924999D1 (de) Lipasehemmer enthaltende pharmazeutische zusammensetzungen
FIU20000164U0 (fi) Uusi farmaseuttinen formulaatio
ATE331529T1 (de) Antigen enthaltende pharmazeutische zusammensetzung
DE69940904D1 (de) Pharmazeutische zusammensetzung enthaltend epothilone
IL152718A0 (en) Piperidine derivatives and pharmaceutical compositions containing the same
ATE284223T1 (de) Zusammensetzung enthaltend ein tramadol und ein antikonvulsives arzneimittel
EE200100022A (et) Tiobensimidasooli derivaadid ja farmatseutiline kompositsioon
DE60138872D1 (de) Azetidinderivate, ihre herstellung und sie enthaltende pharmazeutische zusammensetzungen
DE69904312D1 (de) Pharmazeutische aerosolformulierung
DE69807420T2 (de) Pharmazeutische aerosolzusammensetzung
AT7729U3 (de) Pharmazeutische zusammensetzungen enthaltend amlodipinmaleat
HUP0301949A3 (en) Compounds with a sulfonamide group and pharmaceutical compositions containing these compounds
DE60037816D1 (de) Pharmazeutische formulierung enthaltend megalatran und dessen pro-pharmaka
DE60322454D1 (de) Pharmazeutische Zusammensetzungen zur oralen und topischen Verabreichung
DE10084344T1 (de) Cyclosporin enthaltende pharmazeutische Zusammensetzung
DE59801987D1 (de) Pharmazeutische zusammensetzung enthaltend peptichemio
IL169163A0 (en) Optically active dihydropyridine derivative and pharmaceutical compositions containing the same
DE69830154D1 (de) Pharmazeutische zusammensetzungen
PT1227817E (pt) Composicao farmaceutica aquosa contendo ciclesonida
ATE228839T1 (de) Tizoxanide und nitazoxanide enthaltende pharmazeutische zusammensetzungen
ATE290543T1 (de) Pharmazeutische zusammensetzungen mit oligosacchariden und deren herstellung
ATE447964T1 (de) Eine pharmazeutische formulierung, enthaltend einen inhibitor der carboxypeptidase a und einen thrombin-inhibitor
HUP0203383A3 (en) Aminophenoxyacetamide derivatives and pharmaceutical composition containing thereof
DE60106619D1 (de) Pharmazeutische zusammensetzungen enthaltend tobramycin und xanthangummi

Legal Events

Date Code Title Description
8364 No opposition during term of opposition